专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5519019A N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process for preparing same 失效
标题翻译： N-酰基-2,3-苯并吖庚因衍生物，含有它们的药物组合物及其制备方法
公开(公告)号：US5519019A
公开(公告)日：1996-05-21
申请号：US472454
申请日：1995-06-07
申请人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
发明人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
IPC分类号： C07D491/04 , A61K31/55 , C07D243/02
CPC分类号： C07D491/04
摘要： The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C.sub.1-4 alkylamino, di(C.sub.1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C.sub.1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms;R.sup.1 means hydrogen; or R.sup.1 is absent when a double bond exists between the N(3) and C(4) atoms;R.sup.2 means a C.sub.1-3 alkyl group; orR.sup.1 and R.sup.2 together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms;R.sup.3 means hydrogen or a C.sub.1-4 alkanoyl group;R.sup.4 represents hydrogen; a C.sub.1-6 alkanoyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C.sub.1-4 alkylamino, di(C.sub.1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropane-carbonyl, C.sub.1-5 alkylcarbamoyl or phenylcarbamoyl group; andthe dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R.sup.3 and R.sup.4 stand for hydrogen.The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
摘要翻译：本发明涉及通式（I）的新型N-酰基-2,3-苯并二氮杂萘衍生物，其立体异构体和酸加成盐，含有它们的药物组合物及其制备方法。在通式（I）中，R代表任选被甲氧基，氰基，羧基，氨基，C 1-4烷基氨基，二（C 1-4烷基）氨基，吡咯烷子基，邻苯二甲酰亚胺基或苯基取代的C 1-6烷酰基，或通过一个或多个卤素; 或R是苯甲酰基，环丙烷羰基，C 1-5烷基氨基甲酰基或苯基氨基甲酰基; 或者当N（3）和C（4）原子之间存在双键时，R不存在; R1表示氢; 当N（3）和C（4）原子之间存在双键时，R1不存在; R2表示C1-3烷基; 或者R 1和R 2一起代表亚甲基，N（3）和C（4）原子之间不存在双键; R3表示氢或C1-4烷酰基; R4代表氢; 任选被甲氧基，氰基，羧基，氨基，C1-4烷基氨基，二（C1-4烷基）氨基，吡咯烷子基，苯二甲酰亚氨基或苯基或一个或多个卤素取代的C 1-6烷酰基; 以及苯甲酰基，棕榈酰基，环丙烷 - 羰基，C 1-5烷基氨基甲酰基或苯基氨基甲酰基; 并且虚线表示任选存在的价键，条件是当R3和R4均代表氢时，N（3）和C（4）原子之间不存在双键。通式（I）的化合物具有有价值的中枢神经系统作用，特别是肌肉松弛剂，抗惊厥和神经保护作用。因此，它们可用于治疗中枢神经系统起源的各种疾病。

2. 发明授权

US5639751A N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders 失效
标题翻译：用于治疗急性和慢性神经变性疾病的N-酰基-2,3-苯并二氮杂衍生物
公开(公告)号：US5639751A
公开(公告)日：1997-06-17
申请号：US477801
申请日：1995-06-07
申请人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
发明人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
IPC分类号： C07D491/04 , A61K31/55 , A61K31/44
CPC分类号： C07D491/04
摘要： The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C.sub.1-4 alkylamino, di(C.sub.1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C.sub.1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms;R.sup.1 means hydrogen; or R.sup.1 is absent when a double bond exists between the N(3) and C(4) atoms;R.sup.2 means a C.sub.1-3 alkyl group; orR.sup.1 and R.sup.2 together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms;R.sup.3 means hydrogen or a C.sub.1-4 alkanoyl group;R.sup.4 represents hydrogen; a C.sub.1-6 alkanoyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C.sub.1-4 alkylamino, di(C.sub.1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C.sub.1-5 alkylcarbamoyl or phenylcarbamoyl group; andthe dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R.sup.3 and R.sup.4 stand for hydrogen.The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
摘要翻译：本发明涉及通式（I）的新型N-酰基-2,3-苯并二氮杂萘衍生物，其立体异构体和酸加成盐，含有它们的药物组合物及其制备方法。在通式（I）中，R代表任选被甲氧基，氰基，羧基，氨基，C 1-4烷基氨基，二（C 1-4烷基）氨基，吡咯烷子基，邻苯二甲酰亚胺基或苯基取代的C 1-6烷酰基，或通过一个或多个卤素; 或R是苯甲酰基，环丙烷羰基，C 1-5烷基氨基甲酰基或苯基氨基甲酰基; 或者当N（3）和C（4）原子之间存在双键时，R不存在; R1表示氢; 当N（3）和C（4）原子之间存在双键时，R1不存在; R2表示C1-3烷基; 或者R 1和R 2一起代表亚甲基，N（3）和C（4）原子之间不存在双键; R3表示氢或C1-4烷酰基; R4代表氢; 任选被甲氧基，氰基，羧基，氨基，C1-4烷基氨基，二（C1-4烷基）氨基，吡咯烷子基，苯二甲酰亚氨基或苯基或一个或多个卤素取代的C 1-6烷酰基; 以及苯甲酰基，棕榈酰基，环丙烷羰基，C 1-5烷基氨基甲酰基或苯基氨基甲酰基; 并且虚线表示任选存在的价键，条件是当R3和R4均代表氢时，N（3）和C（4）原子之间不存在双键。通式（I）的化合物具有有价值的中枢神经系统作用，特别是肌肉松弛剂，抗惊厥和神经保护作用。因此，它们可用于治疗中枢神经系统起源的各种疾病。

3. 发明授权

US5536832A N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process for preparing same 失效
标题翻译： N-酰基-2,3-苯并二氮杂衍生物含有它们的药物组合物及其制备方法
公开(公告)号：US5536832A
公开(公告)日：1996-07-16
申请号：US423153
申请日：1995-04-17
申请人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
发明人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
IPC分类号： A61K31/55 , A61K20060101 , A61K31/00 , A61K31/335 , A61K31/395 , A61K31/551 , A61P9/08 , A61P9/10 , A61P21/02 , A61P25/00 , A61P25/08 , A61P25/28 , C07D20060101 , C07D243/00 , C07D243/02 , C07D247/00 , C07D317/00 , C07D317/08 , C07D317/44 , C07D491/00 , C07D491/04 , C07D491/056 , C07D493/04
CPC分类号： C07D491/04
摘要： The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C.sub.1-4 alkylamino, di(C.sub.1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C.sub.1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms;R.sup.1 means hydrogen; or R.sup.1 is absent when a double bond exists between the N(3) and C(4) atoms;R.sup.2 means a C.sub.1-3 alkyl group; orR.sup.1 and R.sup.2 together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms;R.sup.3 means hydrogen or a C.sub.1-4 alkanoyl group;R.sup.4 represents hydrogen; a C.sub.1-6 alkanoyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C.sub.1-4 alkylamino, di(C.sub.1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropane-carbonyl, C.sub.1-5 alkylcarbamoyl or phenylcarbamoyl group; andthe dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R.sup.3 and R.sup.4 stand for hydrogen.The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
摘要翻译：本发明涉及通式（I）的新型N-酰基-2,3-苯并二氮杂萘衍生物，其立体异构体和酸加成盐，含有它们的药物组合物及其制备方法。在通式（I）中，R代表任选被甲氧基，氰基，羧基，氨基，C 1-4烷基氨基，二（C 1-4烷基）氨基，吡咯烷子基，邻苯二甲酰亚胺基或苯基取代的C 1-6烷酰基，或通过一个或多个卤素; 或R是苯甲酰基，环丙烷羰基，C 1-5烷基氨基甲酰基或苯基氨基甲酰基; 或者当N（3）和C（4）原子之间存在双键时，R不存在; R1means氢; 当N（3）和C（4）原子之间存在双键时，R1不存在; R2表示C1-3烷基; 或者R 1和R 2一起代表亚甲基，N（3）和C（4）原子之间不存在双键; R3表示氢或C1-4烷酰基; R4表示氢; 任选被甲氧基，氰基，羧基，氨基，C 1-4烷基氨基，二（C 1-4烷基）氨基，吡咯烷子基，苯二甲酰亚氨基或苯基或被一个或多个卤素取代的C 1-6烷酰基; 以及苯甲酰基，棕榈酰基，环丙烷 - 羰基，C 1-5烷基氨基甲酰基或苯基氨基甲酰基; 并且虚线表示任选存在的价键，条件是当R3和R4均代表氢时，N（3）和C（4）原子之间不存在双键。通式（I）的化合物具有有价值的中枢神经系统作用，特别是肌肉松弛剂，抗惊厥和神经保护作用。因此，它们可用于治疗中枢神经系统起源的各种疾病。

4. 发明授权

US5521174A N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculature therewith 失效
标题翻译： N-酰基-2,3-苯并二氮杂衍生物和治疗骨骼肌肉痉挛的方法
公开(公告)号：US5521174A
公开(公告)日：1996-05-28
申请号：US477799
申请日：1995-06-07
申请人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
发明人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
IPC分类号： C07D491/04 , A61K31/55 , C07D243/02
CPC分类号： C07D491/04
摘要： The invention relates to novel N-acyl-2,3-benzodiezapine derivatives and a method of treating spasms of the skeletal musculature therewith.
摘要翻译：本发明涉及新型N-酰基-2,3-苯并二氮杂衍生物及其治疗骨骼肌肉痉挛的方法。

5. 发明授权

US5459137A N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same 失效
标题翻译： N-酰基-2,3-苯并二氮杂衍生物，含有它们的药物组合物及其制备方法
公开(公告)号：US5459137A
公开(公告)日：1995-10-17
申请号：US80604
申请日：1993-06-21
申请人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
发明人： Ferenc Andrasi , Pal Berzsenyi , Peter Botka , Sandor Farkas , Katalin Goldschmidt , Tamas Hamori , Jeno Korosi , Imre Moravcsik , Istvan Tarnawa
IPC分类号： A61K31/55 , A61K20060101 , A61K31/00 , A61K31/335 , A61K31/395 , A61K31/551 , A61P9/08 , A61P9/10 , A61P21/02 , A61P25/00 , A61P25/08 , A61P25/28 , C07D20060101 , C07D243/00 , C07D243/02 , C07D247/00 , C07D317/00 , C07D317/08 , C07D317/44 , C07D491/00 , C07D491/04 , C07D491/056 , C07D493/04
CPC分类号： C07D491/04
摘要： The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in the specification, a more complete description of the compounds may be found.The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
摘要翻译：本发明涉及通式（I）的新型N-酰基-2,3-苯并二氮杂萘衍生物，其立体异构体和酸加成盐，含有它们的药物组合物及其制备方法。在本说明书中定义的通式（I）中，可以找到更完整的化合物的描述。通式（I）的化合物具有有价值的中枢神经系统作用，特别是肌肉松弛剂，抗惊厥和神经保护作用。因此，它们可用于治疗中枢神经系统起源的各种疾病。

6. 发明授权

US08802672B2 Pyrimidinyl-piperazines useful as D3/D2 receptor ligands 有权
标题翻译：可用作D3 / D2受体配体的嘧啶基哌嗪
公开(公告)号：US08802672B2
公开(公告)日：2014-08-12
申请号：US12979439
申请日：2010-12-28
申请人： Gizella Bartane Szalai , Eva Againe Csongor , Gyorgy Domany , Istvan Gyertyan , Bela Kiss , Judit Laszy , Katalin Saghy , Eva Schmidt , Sandor Farkas , Zsolt Komlodi
发明人： Gizella Bartane Szalai , Eva Againe Csongor , Gyorgy Domany , Istvan Gyertyan , Bela Kiss , Judit Laszy , Katalin Saghy , Eva Schmidt , Sandor Farkas , Zsolt Komlodi
IPC分类号： A61K31/506
CPC分类号： C07D239/48
摘要： The present invention relates to new dopamine D3 and D2 ligands of formula (I): wherein R1, R2 and Q are as described herein, and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes for preparing the same, to compositions containing the same and to their use in the treatment and/or prevention of conditions which requires modulation of dopamine receptors.
摘要翻译：本发明涉及式（I）的新的多巴胺D3和D2配体：其中R1，R2和Q如本文所述，和/或几何异构体和/或立体异构体和/或非对映异构体和/或盐和/或水合物和 /或其溶剂合物和/或其多晶型物。本发明还涉及其制备方法，含有该组合物的组合物及其在治疗和/或预防需要调节多巴胺受体的病症中的用途。

7. 发明授权

US08762592B2 System and method for automatic module selection 有权
标题翻译：自动模块选择的系统和方法
公开(公告)号：US08762592B2
公开(公告)日：2014-06-24
申请号：US11468622
申请日：2006-08-30
申请人： Sandor Farkas , John S. Loffink
发明人： Sandor Farkas , John S. Loffink
IPC分类号： G06F3/00
CPC分类号： G06F1/26
摘要： A selecting device that receives a digital connector ID signal and that generates a device output signal, the connector ID signal being representative of a connector ID for a connector that receives a server module, the device output signal being indicative of whether the server module is selected as a master server. Generating a signal indicative of an information handling system module rank includes generating a connector ID signal when a module is coupled to a chassis connector having a connector ID associated therewith, the connector ID signal being representative of the connector ID, receiving the connector ID signal at a selecting device, and generating a device output signal using the selecting device, the device output signal being indicative of a module rank.
摘要翻译：一种选择装置，其接收数字连接器ID信号并产生装置输出信号，所述连接器ID信号表示用于接收服务器模块的连接器的连接器ID，所述装置输出信号指示是否选择了服务器模块作为主服务器。产生指示信息处理系统模块等级的信号包括当模块耦合到具有与其相关联的连接器ID的机架连接器时产生连接器ID信号，连接器ID信号代表连接器ID，接收连接器ID信号选择装置，以及使用所述选择装置产生装置输出信号，所述装置输出信号指示模块等级。

8. 发明申请

US20140108692A1 System and Method for Integrating Multiple Servers into Single Full Height Bay of a Server Rack Chassis 有权
标题翻译：将多个服务器集成到服务器机架的单个全高度的系统和方法
公开(公告)号：US20140108692A1
公开(公告)日：2014-04-17
申请号：US13650654
申请日：2012-10-12
申请人： Jean Doglio , Bernard D. Strmiska , Brandon J. Brockelsby , Laurent A. Regimbal , Sandor Farkas , Shawn P. Hoss , Vibora Sim
发明人： Jean Doglio , Bernard D. Strmiska , Brandon J. Brockelsby , Laurent A. Regimbal , Sandor Farkas , Shawn P. Hoss , Vibora Sim
IPC分类号： G06F1/16 , G06F13/00
CPC分类号： G06F1/183 , H05K7/1489
摘要： An information handling system includes a server rack chassis, an adaptor assembly, and second and third servers. The server rack chassis includes a bay adapted to receive a first server that has a height that is substantially equal to a height of the bay. The adaptor assembly is inserted within the bay and includes first, second, third, and fourth slots to receive servers. The adaptor assembly is substantially the same size and dimension as the first server. The second server is inserted within the first slot of the adaptor assembly, and includes a first communication fabric. The height of the second server is substantially equal to a quarter of the height of the bay. The third server is inserted within the second slot of the adaptor assembly, and includes a second communication fabric. The height of the third server is substantially equal to a quarter of the height of the bay.
摘要翻译：信息处理系统包括服务器机箱机架，适配器组件以及第二和第三服务器。服务器机箱机架包括适于接收具有基本上等于间隔高度的高度的第一服务器的托架。适配器组件插入在托架内并且包括用于接收服务器的第一，第二，第三和第四插槽。适配器组件与第一服务器基本相同的尺寸和尺寸。第二服务器插入适配器组件的第一槽内，并且包括第一通信结构。第二台服务器的高度基本上等于海湾高度的四分之一。第三服务器被插入适配器组件的第二槽中，并且包括第二通信结构。第三台服务器的高度基本上等于海湾高度的四分之一。

9. 发明申请

US20130029991A1 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists 审中-公开
标题翻译：新的苯基氨磺酰苯甲酰胺衍生物作为缓激肽拮抗剂
公开(公告)号：US20130029991A1
公开(公告)日：2013-01-31
申请号：US13564429
申请日：2012-08-01
申请人： Gyula Beke , Eva Bozo , Sandor Farkas , Katalin Hornok , Gyorgy Keseru , Eva Schmidt , Eva Szentirmay , Istvan Vago , Monika Vastag
发明人： Gyula Beke , Eva Bozo , Sandor Farkas , Katalin Hornok , Gyorgy Keseru , Eva Schmidt , Eva Szentirmay , Istvan Vago , Monika Vastag
IPC分类号： A61K31/445 , C07C303/38 , A61P25/04 , A61P29/00 , C07C311/46 , A61K31/4545 , C07D265/30 , A61K31/5375 , C07D233/64 , A61K31/4174 , C07D401/04 , C07D211/34 , A61K31/18
CPC分类号： C07C311/21 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07D209/08 , C07D211/26 , C07D211/58 , C07D213/40 , C07D213/75 , C07D231/40 , C07D233/54 , C07D233/64 , C07D235/30 , C07D241/08 , C07D261/14 , C07D277/46 , C07D277/62 , C07D277/82 , C07D285/135 , C07D295/13 , C07D295/135 , C07D317/46
摘要： The present invention relates to new sulfonamide derivatives of formula (I) wherein R1-R8 and Z are as defined in the claims, and optical antipodes or racemates and/or salts and/or hydrates and/or solvates thereof, which are selective antagonists of bradykinin B1, to processes for producing these same compounds, pharmacological compositions containing them and to their use in therapy or prevention of painful and inflammatory conditions.
摘要翻译：本发明涉及式（I）的新的磺酰胺衍生物，其中R 1 -R 8和Z如权利要求中所定义，和光学对映体或外消旋体和/或其盐和/或水合物和/或溶剂化物，其是选择性拮抗剂缓激肽B1，用于制备这些相同化合物的方法，含有它们的药理学组合物及其在治疗或预防疼痛和炎症病症中的用途。

10. 发明授权

US07719293B2 System and method for current measurement 有权
标题翻译：用于电流测量的系统和方法
公开(公告)号：US07719293B2
公开(公告)日：2010-05-18
申请号：US11938323
申请日：2007-11-12
申请人： Sandor Farkas
发明人： Sandor Farkas
IPC分类号： G01R27/08
CPC分类号： G01R19/0092
摘要： Load current of a circuit is determined across a component of the circuit by calibrating the resistance of the component with a reference current having a distinguishable characteristic. For example, a reference current with swept frequency modulation is applied to the component so that the resistance of the component is determined from voltage drop associated with the reference current across the component. The component resistance is applied to a voltage drop associated with the load current to determine the load current. For example, a filter matched to the reference current frequency modulation isolates the reference current voltage drop so that a ratio of the reference current voltage drop and the load current voltage drop provides a ratio of the reference current and load current.
摘要翻译：通过用具有可区分特性的参考电流校准元件的电阻来确定电路的元件的负载电流。例如，具有扫频调制的参考电流被施加到组件，使得通过与组件上的参考电流相关联的电压降来确定组件的电阻。元件电阻被施加到与负载电流相关联的电压降以确定负载电流。例如，与参考电流频率调制相匹配的滤波器隔离参考电流电压降，使得参考电流电压降与负载电流电压降的比率提供参考电流和负载电流的比率。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式